PharmaBoardroom

Peter DeYoung – CEO, Global Pharma, Piramal Pharma Limited

Peter DeYoung shares the significance of Indian giant Piramal Pharma's recent demerger from its parent company and its current strategic focus on…

Portugal’s Medical Cannabis Exports Up 63%, On Track to…

Portugal’s strong legal framework along with its low production costs and strategic location within Europe have given rise to a thriving medicinal…

Singapore Pharma News: Evotec’s 65LAB; Novo Nordisk’s…

The latest pharma news from Singapore, including J&J Innovation's continued investment in Singapore; Evotec's new Singaporean venture, 65LAB;…

Digital Transformation: 3 Insights from UCB CEO Jean-Christophe…

UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including…

Germany Pharma News: Bayer’s Latest Woes; New EUR 2 bln…

The latest pharma industry news from Germany, including Lilly's new German plant; Bayer's aborted anti-clotting drug trial and legal worries;…

HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?

Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however…

Broadening Patient Access to Cell Therapies Through the…

Dr Vivienne Marshall, senior director of the Center for Advanced Therapies at the South Texas Blood & Tissue Center, part of BioBridge Global,…

Simão Soares – President, P-BIO

P-BIO, Portugal's leading association for its biotech industry, is approaching a quarter century in existence. Its president, Simão Soares, tells…

Viatris: Building a Sustainable & Accessible Healthcare…

Drawing on a quarter of a century of pharmaceutical industry experience, over 20 years of which has been spent in the UAE, Ayman Mokhtar today heads…

China Pharma News: CanSino Gates Foundation Grant; Merck/Jiangsu…

A roundup of some of the latest news from Chinese pharma including CanSino's Gates Foundation grant for polio vaccine R&D; Merck's deal with…

Pierre Behnam – Director Africa Middle-East Türkiye,…

Pierre Fabre has been present in the Moroccan market for nearly 40 years. Pierre Behnam, the company’s director for Africa, Middle-East and Türkiye…

Anthony Y. Lauw – GM & Head of Human Pharma Northwest…

Dr Anthony Y. Lauw, GM & Head of Human Pharma Northwest Africa at Boehringer Ingelheim, explains the operations of a cluster that has typically…

Tagged with B